World Generic Medicines Congress day 2

08:00

Registration

Generic Market Analysis

Mr Simon Cohen
09:00

Opening remarks from the chair

Mr Simon Cohen, Partner, Taylor Wessing
Apurva Saraf
09:15

Current themes dominating US Generics

Apurva Saraf, Vice President - Global Strategy and Corporate Development, Amneal
Dr Pieter Dylst
09:45

Value of Generic Medicines

Dr Pieter Dylst, Health Economics Officer, E.G.A. European Generic Medicines Association
Claudio Albrecht
10:15

Small is not always Beautiful – The frenzy of M&A in Generics

Claudio Albrecht, Former CEO and Chairman of the Board of Directors, Actavis Group, Founder and Managing Partner, Albrecht, Prock & Partners AG
10:45

Morning refreshments

Mr Sameer Agarwal
11:15

Strategic Marketing: Emerging versus mature markets

Mr Sameer Agarwal, Senior Vice President-Portfolio & Marketing, Mature & Emerging Markets, Frenesius Kabi

Payer Power

Evert Jan van Lente
11:45

Purchasing power: how to influence purchasing decisions

Evert Jan van Lente, Director of EU Affairs, AOK Bundesverdand
Mr Peter Wittner
12:15

An Industry Observer's Perspective on Cost Containment and Procurement of Generics

Mr Peter Wittner, Senior Consultant, Interpharm Consultancy
12:45

Lunch

Panel discussion
14:00

PANEL DISCUSSION: Trends in pricing and profits

Frances Cloud, Founder, Pharmacloud Ltd
Evert Jan van Lente, Director of EU Affairs, AOK Bundesverdand
Mr Peter Wittner, Senior Consultant, Interpharm Consultancy
Dr Clemens Troche, CEO – betapharm & Head – Europe Generics, Dr. Reddy's Laboratories
Saufung Ma
14:30

Legal and IP strategies for the generic medicines

Saufung Ma, Senior Associate, Taylor Wessing
Mr Simon Cohen, Partner, Taylor Wessing
15:00

Afternoon refreshments

Mr David Jauch
15:30

Advantages of Trade Policy to the generic and biosimilar industry

Mr David Jauch, Global Regulatory Affairs and Government Relations Manager, Fresenius Kabi
Mr Antonio Lopez
16:00

Generics product development from a CDMO perspective

Reserved for GB Patent
Mr Antonio Lopez, Director of Business Management for Spain, Portugal and France, Recipharm
Antonio Lopez, Director of Business Management for Spain, Portugal and France, Recipharm
16:30

Closing remarks from the chair

last published: 10/Feb/16 06:25 GMT
BOOK NOW